Lipocine vs NRX Pharmaceuticals
LPCN and NRXP side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How LPCN and NRXP compare
NRX Pharmaceuticals is the larger company, worth 6.8 times as much as Lipocine ($93.1M against $13.7M).
NRX Pharmaceuticals keeps more of each dollar of sales as profit, with a net margin of −692% compared with −755% at Lipocine.
Lipocine scores higher on the StockData Score (9 against 0 for NRX Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | LPCN | NRXP |
|---|---|---|
| Size and price | ||
| Market cap | $13.7M | $93.1M |
| Share price | $1.66 | $2.15 |
| Change, 1 year | −41.1% | −17.0% |
| Change, 5 years | −91.4% | −96.8% |
| Beta (5Y) | −0.43 | 1.35 |
| Employees | 14 | 29 |
| StockData Score | ||
| Total score | 9 (better) | 0 |
| Valuation score | 3 (better) | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 5 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 8.7× (better) | 27.4× |
| P/B | 0.6× | – |
| Fair value | $2.62 | – |
| Margin of safety | 36.5% | – |
| Growth | ||
| Revenue growth (TTM) | −62.7% | – |
| Profitability | ||
| Gross margin | – | 46.6% |
| Operating margin | −801% | −586% (better) |
| Net margin | −755% | −692% (better) |
| Return on equity | −60.9% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −17.4× |
| Current ratio | 11.48 (better) | 0.86 |
| Altman Z-score | −9.28 (better) | −13.67 |
| Piotroski F-score | 1 | 5 (better) |
| Dividends and buybacks | ||
| Buyback yield | −119% | – |
| Shareholder yield | −119% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 36.2% | 26.9% |
| Held by insiders | 9.0% | 15.6% |
| Insider net buying, 12 months | $596K | – |
| Short interest, % of float | 4.3% | 28.6% |
Go deeper
- LPCN stock overview
- LPCN income statement
- LPCN valuation and score
- NRXP stock overview
- NRXP income statement
- NRXP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.